Huayi Liu

Dr. Huayi Liu

State key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, China
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2018 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
BLBing Liu
Bing Liu
LHLihui He
Lihui He
LWLiping Wang
Liping Wang
TLTao Li
Tao Li
CLChangcheng Li
Changcheng Li
RBRui Bao
Rui Bao

1 March 2021 in Cell Host & Microbe
Verified
Journal Article
Closed access
JLJing-wen Lin
Jing-wen Lin
CTChao Tang
Chao Tang
HWHan-Cheng Wei
Han-Cheng Wei
BDBaowen Du
Baowen Du
CCChuan Chen
Chuan Chen
LCLu Chen
Lu Chen

29 September 2020 in Microbial Biotechnology
Verified
Journal Article
Open access
PDF file
HLHuayi Liu
Huayi Liu
YTYujuan Tian
Yujuan Tian
YZYi Zhou
Yi Zhou
YKYeyi Kan
Yeyi Kan
TWTingting Wu
Tingting Wu
YLYunzi Luo
Yunzi Luo
Summary: Tyrosol and its glycosylated product salidroside are important ingredients in pharmaceuticals, nutraceuticals and cosmetics. Despite the ability of Saccharomyces cerevisiae to naturally synthesize tyrosol, high yield from de novo synthesis remains a challenge. Here, we used metabolic engineering strategies to construct S. cerevisiae strains for high‐level production of tyrosol and salidroside from glucose. First, tyrosol production was unlocked from feedback inhibition. Then, transketolase and ribose‐5‐phosphate ketol‐isomerase were overexpressed to balance the supply of precursors. Next, chorismate synthase and chorismate mutase were overexpressed to maximize the aromatic amino acid flux towards tyrosol synthesis. Finally, the competing pathway was knocked out to further direct the carbon flux into tyrosol synthesis. Through a combination of these interventions, tyrosol titres reached 702.30 ± 0.41 mg l −1 in shake flasks, which were approximately 26‐fold greater than that of the WT strain. RrU8GT33 from Rhodiola rosea was also applied to cells and maximized salidroside production from tyrosol in S. cerevisiae . Salidroside titres of 1575.45 ± 19.35 mg l −1 were accomplished in shake flasks. Furthermore, titres of 9.90 ± 0.06 g l −1 of tyrosol and 26.55 ± 0.43 g l −1 of salidroside were achieved in 5 l bioreactors, both are the highest titres reported to date. The synergistic engineering strategies presented in this study could be further applied to increase the production of high value‐added aromatic compounds derived from the aromatic amino acid biosynthesis pathway in S. cerevisiae .

8 November 2022 in ACS Synthetic Biology
Verified
Journal Article
Closed access
HLHuayi Liu
Huayi Liu
XWXinxin Wu
Xinxin Wu
HMHe Ma
He Ma
JLJian Li
Jian Li
ZLZhenyu Liu
Zhenyu Liu
YLYunzi Luo
Yunzi Luo

28 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJialu Li
Jialu Li
HLHuayi Liu
Huayi Liu
JLJian Li
Jian Li
JLJuxiu Liu
Juxiu Liu
XDXinli Dai
Xinli Dai
XWXiang Wang
Xiang Wang
β-1,3 Glucan synthase (GS) is essential for fungal cell wall biosynthesis. The GS holoenzyme comprises the glycosyltransferase FKS1 and its regulatory factor Rho1, a small GTPase. However, the mechanism by which Rho1 activates FKS1 in a GTP-dependent manner remains unclear. Here, we present two cryo-EM structures of FKS1, apo and in complex with Rho1. FKS1 adopts a cellulose synthase-like conformation. The interaction between Rho1 and FKS1 is enhanced in the presence of GTPγS. Rho1 is positioned within a pocket between the glycosyltransferase domain of FKS1 (GT domain) and the transmembrane helix spanning TM7-15. Comparison of the two structures reveals extensive conformational changes within FKS1. These alterations suggest that Rho1’s GTP/GDP cycling may act as a molecular pump, promoting a dynamic transition between the resting and active states of FKS1. Notably, Rho1 triggers FKS1 conformational changes that may push the growing glucan chain into FKS1’s transmembrane channel, thereby facilitating β-1,3-glucan elongation.

15 July 2023 in Communications Chemistry
Verified
Journal Article
Open access
PDF file
HLHuayi Liu
Huayi Liu
QXQingjie Xiao
Qingjie Xiao
XWXinxin Wu
Xinxin Wu
HMHe Ma
He Ma
JLJian Li
Jian Li
YLYunzi Luo
Yunzi Luo
3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (DAHPS) is a key enzyme in the shikimate pathway for the biosynthesis of aromatic compounds. L-Phe and L-Tyr bind to the two main DAHPS isoforms and inhibit their enzyme activities, respectively. Synthetic biologists aim to relieve such inhibitions in order to improve the productivity of aromatic compounds. In this work, we reported a point mutant of yeast DHAPS, Aro3D154N, which retains the wild type enzyme activity but converts it highly inert to the inhibition by L-Phe. The Aro3 crystal structure along with the molecular dynamics simulations analysis suggests that the D154N mutation distant from the inhibitor binding cavity may reduce the binding affinity of L-Phe. Growth assays demonstrated that substitution of the conserved D154 with asparagine suffices to relieve the inhibition of L-Phe on Aro3, L-Tyr on Aro4, and the inhibitions on their corresponding homologues from diverse yeasts. The importance of our discovery is highlighted by the observation of 29.1% and 43.6% increase of yield for the production of tyrosol and salidroside respectively upon substituting ARO3 with ARO3D154N. We anticipate that this allele would be used broadly to increase the yield of various aromatic products in metabolically diverse microorganisms.